Related Experiment Videos

5-HT2 receptors, roles and regulation

J E Leysen1, P J Pauwels

  • 1Department of Biochemical Pharmacology, Janssen Research Foundation, Beerse, Belgium.

Insights

Stimulation of serotonin 5-HT2 receptors by agonists causes negative effects, while antagonists offer therapeutic benefits. Both agonists and antagonists can lead to a decrease in 5-HT2 receptor density, impacting neurological and circulatory functions.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Cell Biology

Background:

  • Serotonin 5-HT2 receptor agonists induce adverse neurological, psychological, and circulatory effects.
  • 5-HT2 receptor antagonists mitigate these effects and show therapeutic potential for conditions like schizophrenia and impaired circulation.
  • Chronic antagonist use in rodents has been linked to receptor desensitization and downregulation.

Purpose of the Study:

  • To investigate the in vivo and in vitro regulation of 5-HT2 receptors following agonist and antagonist treatment.
  • To examine the effects of DOM (agonist) and ketanserin (antagonist) on 5-HT2 receptor density and function.
  • To understand the desensitization and resensitization mechanisms of 5-HT2 receptors.

Main Methods:

  • Administered DOM (agonist) and ketanserin (antagonist) to rats, monitoring head twitch response and quantifying frontal cortical 5-HT2 receptors using [3H]ketanserin.
  • Utilized cultured vascular smooth muscle cells to study 5-HT2 receptor-mediated inositol phosphate formation in response to 5-HT, DOM, setoperone, and ketanserin.
  • Assessed receptor resensitization and degradation kinetics in vivo and in vitro.

Main Results:

  • DOM treatment rapidly desensitized the head twitch response and decreased frontal cortical 5-HT2 receptor density.
  • Ketanserin administration, even when given before the agonist, did not prevent agonist-induced receptor downregulation.
  • Ketanserin alone, with repeated administration, reduced the binding of both antagonist ([3H]ketanserin) and agonist ([3H]DOB) ligands, indicating a decrease in total 5-HT2 receptors.
  • In vitro, agonist treatment desensitized 5-HT2 receptor-mediated signaling, followed by resensitization.
  • Antagonist pretreatment (ketanserin, setoperone) in vitro reduced receptor-mediated signaling without preventing subsequent desensitization.

Conclusions:

  • Both 5-HT2 receptor agonists and antagonists can lead to a decrease in receptor number.
  • The regulation of 5-HT2 receptors involves complex desensitization and resensitization processes.
  • Findings suggest potential therapeutic implications for understanding 5-HT2 receptor modulation in various physiological and pathological conditions.

Related Concept Videos